Picture of SenzaGen AB logo

SENZA SenzaGen AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for SenzaGen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-27.2-31.3-24.9-22.1-17.9
Depreciation
Deferred Taxes
Non-Cash Items0.5590.0060.225-0.1782.79
Unusual Items
Other Non-Cash Items
Changes in Working Capital-6.596.09-0.797-5.77-5.65
Change in Accounts Receivable
Change in Inventories
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-29.4-21-16.1-16.5-9.33
Capital Expenditures-0.021-0.331-0.607-0.129-0.656
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.42-26.2-12.8-5.95-3.59
Acquisition of Business
Sale of Business
Change in Net Investments
Change in Net Intangibles
Cash from Investing Activities-2.45-26.6-13.4-6.08-4.25
Financing Cash Flow Items0-2.31-0.0420-2.65
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.69827.30.0310.14735.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-31.1-20.2-29.2-22.422